当前位置:产品中心 > 抗体 > Biosimilar抗体 > Anti-AAV2 mIgG1 Antibody
Anti-AAV2 mIgG1 Antibody
基本信息

产品编号:GM-71168AB

产品名称:Anti-AAV2 mIgG1 Antibody

目录价:询价


产品配图.jpg


规格货号

GM-71168AB-10           10 μg

GM-71168AB-100         100 μg

GM-71168AB-1000       1mg


产品简介

Species Reactivity      Human

Specificity                   Detects Adeno-associated virus

Source/Isotype           Monoclonal Mouse IgG1

Application                 Neutralization Assay: 1.8 ng/mL-30 μg/mL

Background                Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies. The ability to generate recombinant AAV particles lacking any viral genes and containing DNA sequences of interest for various therapeutic applications has thus far proven to be one of the safest strategies for gene therapies.  The AAV2 capsid (intact particle) comprises three types of subunits, VP1, VP2, and VP3, a total of 60 copies in a ratio of 1:1:8 (VP1:VP2:VP3). This antibody recognizes a conformational epitope of assembled AAV2 capsids.

Storage                       Store at +4℃ short term (1-2 weeks). Store at -20℃ long term

Formulation                Phosphate-buffered solution, pH 7.2.

数据展示

GM-71168AB-1.png

当前位置:产品中心 > 抗体 > Biosimilar抗体 > Anti-AAV2 mIgG1 Antibody

Anti-AAV2 mIgG1 Antibody
基本信息

产品编号:GM-71168AB

产品名称:Anti-AAV2 mIgG1 Antibody

目录价:询价


产品配图.jpg


规格货号

GM-71168AB-10           10 μg

GM-71168AB-100         100 μg

GM-71168AB-1000       1mg


产品简介

Species Reactivity      Human

Specificity                   Detects Adeno-associated virus

Source/Isotype           Monoclonal Mouse IgG1

Application                 Neutralization Assay: 1.8 ng/mL-30 μg/mL

Background                Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies. The ability to generate recombinant AAV particles lacking any viral genes and containing DNA sequences of interest for various therapeutic applications has thus far proven to be one of the safest strategies for gene therapies.  The AAV2 capsid (intact particle) comprises three types of subunits, VP1, VP2, and VP3, a total of 60 copies in a ratio of 1:1:8 (VP1:VP2:VP3). This antibody recognizes a conformational epitope of assembled AAV2 capsids.

Storage                       Store at +4℃ short term (1-2 weeks). Store at -20℃ long term

Formulation                Phosphate-buffered solution, pH 7.2.

数据展示

GM-71168AB-1.png

Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交